Substance use and CD4/CD8 ratio in HIV/HCV co-infected people receiving direct-acting antiviral treatment (ANRS CO13 HEPAVIH)

J Viral Hepat. 2023 Nov;30(11):897-900. doi: 10.1111/jvh.13865. Epub 2023 Jun 26.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use
  • CD8-Positive T-Lymphocytes
  • Coinfection* / drug therapy
  • HIV Infections* / complications
  • HIV Infections* / drug therapy
  • Hepatitis C, Chronic* / complications
  • Hepatitis C, Chronic* / drug therapy
  • Humans
  • Substance-Related Disorders*

Substances

  • Antiviral Agents